Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 2063 results found since Jan 2013.
A New Vaccine to Prevent Herpes Zoster
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - April 29, 2015 Category: Internal Medicine Tags: article Source Type: research
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - April 28, 2015 Category: Internal Medicine Tags: article Source Type: research
Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
New England Journal of Medicine, Volume 373, Issue 16, Page 1575-1577, October 2015.
Source: New England Journal of Medicine - October 14, 2015 Category: Internal Medicine Tags: article Source Type: research
The role of vaccination in successful independent ageing
Publication date: Available online 12 February 2016 Source:European Geriatric Medicine Author(s): J.E. McElhaney, G. Gavazzi, J. Flamaing, J. Petermans Ageing increases the risk and severity of infectious diseases, especially when chronic diseases are present. Healthcare providers generally view vaccination as a childhood intervention and consider vaccination of the elderly not to be sufficiently effective due to immunosenescence. However, the burden of frequent vaccine-preventable diseases, such as influenza, pneumococcal disease and herpes zoster, increases with age, so that the perceived lower vaccine effectivenes...
Source: European Geriatric Medicine - February 14, 2016 Category: Geriatrics Source Type: research
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
New England Journal of Medicine,Volume 375, Issue 11, Page 1019-1032, September 2016.
Source: New England Journal of Medicine - September 13, 2016 Category: Internal Medicine Authors: Anthony L. Cunningham Himal Lal Martina Kovac Roman Chlibek Shinn-Jang Hwang Javier D íez-Domingo Olivier Godeaux Myron J. Levin Janet E. McElhaney Joan Puig-Barber à Carline Vanden Abeele Timo Vesikari Daisuke Watanabe Toufik Zahaf Anitta Ahonen Eugene Source Type: research
National and State-Specific Shingles Vaccination Among Adults Aged ≥60 Years
Conclusions Coverage varied dramatically by state. State-level comparisons may aid in designing tailored intervention programs through sharing of best practices. Strategies are needed to mitigate financial barriers for both provider and patients, improve awareness, and increase provider recommendation of the vaccine.
Source: American Journal of Preventive Medicine - October 5, 2016 Category: Global & Universal Source Type: research
Herpes Zoster Vaccine Coverage in Older Adults in the U.S., 2007 –2013
Conclusions Estimated HZ vaccine coverage is 19.5% in adults aged ≥60 years, which is lower than the Healthy People 2020 target of 30%. Providers should identify every opportunity for HZ vaccination to assure that older adults are protected from HZ, a vaccine-preventable disease.
Source: American Journal of Preventive Medicine - December 14, 2016 Category: Global & Universal Source Type: research
Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.
Conclusions Under current assumptions, a booster dose of herpes zoster vaccine would be cost effective for all vaccinated people 10 years after initial vaccination.
Source: American Journal of Preventive Medicine - November 16, 2017 Category: International Medicine & Public Health Source Type: research
What ’s the point of a perfect patient chart?
Last week I made a patient’s chart perfect.
Not bragging, but ultimately it ended up being pretty easy, and I’ll explain how and why in a little bit.
This was a patient I had not seen in several years, with a number of chronic medical problems, for which he had been taking less than optimal care of himself since I had seen him last.
Here for a “checkup,” we talked about his health conditions and how he had been over the past few years. I got a little update on his family and all the things he had been up to, and then he and I — along with his wife, who was here with him for the appointment ...
Source: Kevin, M.D. - Medical Weblog - January 18, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/fred-n-pelzman" rel="tag" > Fred N. Pelzman, MD < /a > Tags: Physician Health IT Primary Care Source Type: blogs
Herpes Zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate.
CONCLUSION: In tofacitinib users, HZ occurred at a rate of approximately 4% per year and was further doubled with GC exposure. Concomitant MTX did not confer additional risk. Zoster vaccination may decrease risk. This article is protected by copyright. All rights reserved.
PMID: 30295428 [PubMed - as supplied by publisher]
Source: Herpes - October 8, 2018 Category: Infectious Diseases Authors: Curtis JR, Xie F, Yang S, Bernatsky S, Chen L, Yun H, Winthrop K Tags: Arthritis Care Res (Hoboken) Source Type: research
Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research
Fight Aging! Newsletter, June 5th 2023
In conclusion, higher BMR might reduce lifespan. The underlying pathways linking to major causes of death and relevant interventions warrant further investigation.
Betting Against Progress Turns Out Poorly, But Can Work in the Short Term in a Slow Field
https://www.fightaging.org/archives/2023/06/betting-against-progress-turns-out-poorly-but-can-work-in-the-short-term-in-a-slow-field/
Setting oneself up as a spokesperson for "we will not achieve this goal", as the fellow noted here is choosing to do, is a bet against technological progress. A glance at any few decade period in the past two hundred year...
Source: Fight Aging! - June 4, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Fight Aging! Newsletter, May 16th 2016
In this study the authors demonstrate that, as in many other cases, the methodology of delivery matters just as much as the details of the cells used:
Retinal and macular degenerative diseases affect millions of people worldwide. Similar to other neurodegenerative diseases, there are no effective treatments that can stop retinal degeneration or restore degenerative retina. Recent advances in stem cell technology led to development of novel cell-based therapies, some are already in phase I/II clinical trials. Studies from our group and others suggest that human bone marrow-derived mesenchymal stem cells (hBM-MSC) m...
Source: Fight Aging! - May 15, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Fight Aging! Newsletter, May 25th 2020
In conclusion, our results suggest a previously unknown mechanism whereby the canonical NF-κB cascade and a mitochondrial fission pathway interdependently regulate endothelial inflammation.
Lin28 as a Target for Nerve Regeneration
https://www.fightaging.org/archives/2020/05/lin28-as-a-target-for-nerve-regeneration/
Researchers here show that the gene Lin28 regulates axon regrowth. In mice, raised levels of Lin28 produce greater regeneration of nerve injuries. Past research has investigated Lin28 from the standpoint of producing a more general improvement in regenerative capacity. It improves mitochondri...
Source: Fight Aging! - May 24, 2020 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Fight Aging! Newsletter, September 4th 2023
In conclusion, although the contribution of CRF to GrimAgeAccel and FitAgeAccel is relatively low compared to lifestyle-related factors such as smoking, the results suggest that the maintenance of CRF is associated with delayed biological ageing in older men.
« Back to Top
Release of Acetylcholine is Necessary for the Aging Brain to Compensate for a Lack of Neurogenesis
https://www.fightaging.org/archives/2023/09/release-of-acetylcholine-is-necessary-for-the-aging-brain-to-compensate-for-a-lack-of-neurogenesis/
Neurogenesis is the process by which new neurons are created by neural stem ce...
Source: Fight Aging! - September 3, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
